James has been writing about technology for years but has loved it since the early 90s. While his main areas of expertise are maker tools -- 3D printers, vinyl cutters, paper printers, and laser ...
Dec 24, 2025, 12:06 AM IST Sequent Scientific - Announcement under Regulation 30 (LODR)-Change in Management Dec 17, 2025, 12:28 AM IST Sequent Scientific - Announcement under Regulation 30 ...
Editor’s Note: December 10, 2025: We’ve reviewed these selections to ensure they are available and competitively priced. To further update our coverage, with a focus on ease-of-use, we’ve called in ...
SeQuent Scientific (SEQU) has delivered a 20.59% change over the past year, with a 52-week range between 117.35 and 257.85. What Is the Average Daily Trading Volume of SeQuent Scientific (SEQU)? The ...
Explore the NSE:SEQU financials. Find the SeQuent Scientific financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key ...
A 3D shape with all straight edges and flat faces is a polyhedron. Other 3D shapes with least one curved surface are not polyhedra. A 3D shape with regular polygonal faces, meeting at equal angles, is ...
The interventional approach to treat peripheral artery occlusive disease (PAOD) as a treatment of choice is gaining continuous acceptance. SeQuent ® Please OTW offers a targeted, polymer-free and ...
Sequent Scientific Ltd. is a Public Limited Listed company incorporated on 28/06/1985 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) ...
Visistha Traders & Finance Ltd has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on ...
SEQUENT Q4 Results: Check out SeQuent Scientific Q4 Result news, SeQuent Scientific Q4 Earnings result updates and highlights. | SEQUENT Q4 Results 2025 ...
Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.